251 related articles for article (PubMed ID: 22649206)
1. Psoriasis alters HDL composition and cholesterol efflux capacity.
Holzer M; Wolf P; Curcic S; Birner-Gruenberger R; Weger W; Inzinger M; El-Gamal D; Wadsack C; Heinemann A; Marsche G
J Lipid Res; 2012 Aug; 53(8):1618-24. PubMed ID: 22649206
[TBL] [Abstract][Full Text] [Related]
2. Anti-psoriatic therapy recovers high-density lipoprotein composition and function.
Holzer M; Wolf P; Inzinger M; Trieb M; Curcic S; Pasterk L; Weger W; Heinemann A; Marsche G
J Invest Dermatol; 2014 Mar; 134(3):635-642. PubMed ID: 23985995
[TBL] [Abstract][Full Text] [Related]
3. Biological anti-psoriatic therapy profoundly affects high-density lipoprotein function.
Trakaki A; Wolf P; Weger W; Eichmann TO; Scharnagl H; Stadler JT; Salmhofer W; Knuplez E; Holzer M; Marsche G
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Jul; 1866(7):158943. PubMed ID: 33862237
[TBL] [Abstract][Full Text] [Related]
4. Antipsoriatic treatment extends beyond the skin: recovering of high-density lipoprotein function.
Marsche G; Holzer M; Wolf P
Exp Dermatol; 2014 Oct; 23(10):701-4. PubMed ID: 24980461
[TBL] [Abstract][Full Text] [Related]
5. Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacity.
Cukier AMO; Therond P; Didichenko SA; Guillas I; Chapman MJ; Wright SD; Kontush A
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):890-900. PubMed ID: 28529180
[TBL] [Abstract][Full Text] [Related]
6. Aging affects high-density lipoprotein composition and function.
Holzer M; Trieb M; Konya V; Wadsack C; Heinemann A; Marsche G
Biochim Biophys Acta; 2013 Sep; 1831(9):1442-8. PubMed ID: 23792422
[TBL] [Abstract][Full Text] [Related]
7. Psoriasis decreases the anti-oxidation and anti-inflammation properties of high-density lipoprotein.
He L; Qin S; Dang L; Song G; Yao S; Yang N; Li Y
Biochim Biophys Acta; 2014 Dec; 1841(12):1709-15. PubMed ID: 25240836
[TBL] [Abstract][Full Text] [Related]
8. Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis.
Mehta NN; Li R; Krishnamoorthy P; Yu Y; Farver W; Rodrigues A; Raper A; Wilcox M; Baer A; DerOhannesian S; Wolfe M; Reilly MP; Rader DJ; VanVoorhees A; Gelfand JM
Atherosclerosis; 2012 Sep; 224(1):218-21. PubMed ID: 22858285
[TBL] [Abstract][Full Text] [Related]
9. High-Density Lipoprotein Proteomic Composition, and not Efflux Capacity, Reflects Differential Modulation of Reverse Cholesterol Transport by Saturated and Monounsaturated Fat Diets.
O'Reilly M; Dillon E; Guo W; Finucane O; McMorrow A; Murphy A; Lyons C; Jones D; Ryan M; Gibney M; Gibney E; Brennan L; de la Llera Moya M; Reilly MP; Roche HM; McGillicuddy FC
Circulation; 2016 May; 133(19):1838-50. PubMed ID: 27081117
[TBL] [Abstract][Full Text] [Related]
10. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins.
Wang N; Lan D; Chen W; Matsuura F; Tall AR
Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9774-9. PubMed ID: 15210959
[TBL] [Abstract][Full Text] [Related]
11. The molecular structure of apolipoprotein A-II modulates the capacity of HDL to promote cell cholesterol efflux.
Bernini F; Calabresi L; Bonfadini G; Franceschini G
Biochim Biophys Acta; 1996 Jan; 1299(1):103-9. PubMed ID: 8555242
[TBL] [Abstract][Full Text] [Related]
12. Oxidation of high density lipoproteins: characterization and effects on cholesterol efflux from J774 macrophages.
Rifici VA; Khachadurian AK
Biochim Biophys Acta; 1996 Jan; 1299(1):87-94. PubMed ID: 8555257
[TBL] [Abstract][Full Text] [Related]
13. Proteomic analysis of HDL from inbred mouse strains implicates APOE associated with HDL in reduced cholesterol efflux capacity via the ABCA1 pathway.
Pamir N; Hutchins P; Ronsein G; Vaisar T; Reardon CA; Getz GS; Lusis AJ; Heinecke JW
J Lipid Res; 2016 Feb; 57(2):246-57. PubMed ID: 26673204
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis.
Charles-Schoeman C; Lee YY; Grijalva V; Amjadi S; FitzGerald J; Ranganath VK; Taylor M; McMahon M; Paulus HE; Reddy ST
Ann Rheum Dis; 2012 Jul; 71(7):1157-62. PubMed ID: 22267330
[TBL] [Abstract][Full Text] [Related]
15. HDL acceptor capacities for cholesterol efflux from macrophages and lipid transfer are both acutely reduced after myocardial infarction.
Soares AAS; Tavoni TM; de Faria EC; Remalay AT; Maranhão RC; Sposito AC;
Clin Chim Acta; 2018 Mar; 478():51-56. PubMed ID: 29274325
[TBL] [Abstract][Full Text] [Related]
16. Uremia alters HDL composition and function.
Holzer M; Birner-Gruenberger R; Stojakovic T; El-Gamal D; Binder V; Wadsack C; Heinemann A; Marsche G
J Am Soc Nephrol; 2011 Sep; 22(9):1631-41. PubMed ID: 21804091
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol efflux to high-density lipoproteins and apolipoprotein A-I phosphatidylcholine complexes is inhibited by ethanol: role of apolipoprotein structure and cooperative interaction of phosphatidylcholine and cholesterol.
Avdulov NA; Chochina SV; Igbavboa U; Wood WG
Biochemistry; 2000 Aug; 39(34):10599-606. PubMed ID: 10956052
[TBL] [Abstract][Full Text] [Related]
18. Cell surface-expressed moesin-like HDL/apoA-I binding protein promotes cholesterol efflux from human macrophages.
Matsuyama A; Sakai N; Hiraoka H; Hirano K; Yamashita S
J Lipid Res; 2006 Jan; 47(1):78-86. PubMed ID: 16251720
[TBL] [Abstract][Full Text] [Related]
19. Diabetes Impairs Cellular Cholesterol Efflux From ABCA1 to Small HDL Particles.
He Y; Ronsein GE; Tang C; Jarvik GP; Davidson WS; Kothari V; Song HD; Segrest JP; Bornfeldt KE; Heinecke JW
Circ Res; 2020 Oct; 127(9):1198-1210. PubMed ID: 32819213
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein A-I glycation by glucose and reactive aldehydes alters phospholipid affinity but not cholesterol export from lipid-laden macrophages.
Brown BE; Nobecourt E; Zeng J; Jenkins AJ; Rye KA; Davies MJ
PLoS One; 2013; 8(5):e65430. PubMed ID: 23741493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
